It’s quite hard to reconcile the value on offer here to other medtech growth stocks
VTI. 25m MC, unique IP, $9.6m AUD revenues, 100% year of year revenue growth, multi bn global distribution partners now selling
MDR $106m MC, $9.6m revenue, 16.5% annual revenue growth
EMV $137m MC 1.6m revenue
etc
im sure there are other examples good and bad but if VTI keeps growing revenue 100% per year like it has last 3 years that’s $20m AUD then $40m AUD. With the scale of the distribution partners now onboard this seems actually realistic
what will VTI be worth in 2 years if it has $40m revenue? Anyway I bought another mil this am and averaged up regardless of macro crash fears. If it drops back below 2c in a market crash through loss of liquidity will buy more
DYOR
It’s quite hard to reconcile the value on offer here to other...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.503M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6994 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 78 | 1 |
View Market Depth
| Last trade - 16.12pm 18/09/2024 (20 minute delay) ? |
| VTI (ASX) Chart |
Day chart unavailable